Find clinical trials for Diabetes in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Rochester, MN, USA:
Evaluating the adverse events and tolerance of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients...
Phase 1
Rochester, Minnesota, United States and 1 other location
A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...
Rochester, Minnesota, United States and 20 other locations
are interested to evaluate the effect of BKR-017 (colon-targeted 500 mg butyrate tablets) as adjuvant therapy on metabolic control in type 1 diabetes...
Phase 1, Phase 2
Rochester, Minnesota, United States
The purpose of this study is to collect clinical data to support a 7-day wear of the Extended Wear Infusion Set (EWIS).Participants will be asked to:...
Rochester, Minnesota, United States and 14 other locations
Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...
Rochester, Minnesota, United States and 37 other locations
for endoscopic duodenal mucosal regeneration in patients with type 2 Diabetes inadequately controlled on 2-3 non-insulin glucose-lowering me...
Rochester, Minnesota, United States and 2 other locations
fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...
Phase 3
Rochester, Minnesota, United States and 59 other locations
cortisol-secreting adrenal adenoma or hyperplasia associated with diabetes mellitus/ impaired glucose tolerance and/or uncontrolled systolic...
Phase 3
Rochester, Minnesota, United States and 47 other locations
This is study with SPI-62 to evaluate the efficacy, safety, and pharmacological effect of SPI-62 in subjects with hypercortisolism related to a benig...
Phase 2
Rochester, Minnesota, United States and 4 other locations
This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully...
Phase 2
Rochester, Minnesota, United States and 49 other locations
Clinical trials
Research sites
Resources
Legal